Our data suggest that ex vivo bone marrow purging using monoclonal antibodies (MoAbs) and sheep-anti-mouse immunobeads (SAM beads) prior to autologous bone marrow transplantation (ABMT) allows satisfactory tumor cell reduction without critical stem cell losses. Nevertheless, there is only a reduction but no elimination of tumor cells. The consequences will have to be clinically discussed.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1159/000222649 | DOI Listing |
Publication Analysis
Top Keywords
bone marrow
12
marrow purging
8
prior autologous
8
purging prior
4
autologous transplantation
4
transplantation data
4
data vivo
4
vivo bone
4
purging monoclonal
4
monoclonal antibodies
4
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!